UCLA Integrated Substance Abuse Program — Los Angeles, California

UCLA Integrated Substance Abuse Program is a clinical research site located in Los Angeles, California, United States 90025.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Integrated Substance Abuse Program has participated in 7 clinical trials.

Therapeutic areas: Methamphetamine Dependence, Cocaine-Related Disorders, Alcohol-Related Disorders.

Sponsors: National Institute on Drug Abuse (NIDA).

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Integrated Substance Abuse Program?

UCLA Integrated Substance Abuse Program has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Integrated Substance Abuse Program conducted?

UCLA Integrated Substance Abuse Program has 7 clinical trials on record. Their work covers Methamphetamine Dependence, Cocaine-Related Disorders, Alcohol-Related Disorders.

Is UCLA Integrated Substance Abuse Program accredited by Crixeo Health?

UCLA Integrated Substance Abuse Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Integrated Substance Abuse Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.